Abstract
There is a decline in male fertility thus new treatments are needed. To test the efficacy of a new dietary supplement developed in the USA and registered as a drug of cure in Hungary (OGYI). In a clinical trial 100 men with low sperm quality (spermium count 5-20 M/ml, good motility 10-40%, and adverse shape 30-50%) were examined. Sperm parameters were measured before and after a 3-month treatment and after another 3-month without treatment. This dietary supplement statistically and clinically significantly improved sperm count and motility. In 74 cases this dietary supplement demonstrated a beneficial effect on sperm quality (more than 10% increase in sperm count, or quality of motility, or shape); in 16 cases the improvement exceeded 30%. No adverse effect could be accounted for this treatment. This new dietary supplement may contribute to the treatment of male infertility.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
